New Results on Treatment of Gynaecological Cancers - European Cancer Congress (ESMO) 2023 patients today 59:38 1 year ago 256 Далее Скачать
ASCO 2023 Expert Report on novelties in the treatment of gynaecological malignancies, by P. Harter European Society for Medical Oncology (ESMO) 6:03 1 year ago 759 Далее Скачать
ESMO Gynaecological Cancers Congress: key developments in ovarian cancer VJOncology 3:31 3 years ago 98 Далее Скачать
New Results on Treatment of Early Breast Cancer - European Cancer Congress (ESMO) 2023 patients today 44:52 1 year ago 235 Далее Скачать
Highlights on Tisotumab Vedotin 2L or 3L Recurrent or Metastatic Cervical Cancer: innovaTV 301 European Society for Medical Oncology (ESMO) 2:10 1 year ago 934 Далее Скачать
New Results on Treatment of Metastatic Breast Cancer - European Cancer Congress (ESMO) 2023 patients today 40:53 1 year ago 191 Далее Скачать
New approaches to ovarian cancer treatment - Prof Christina Fotopoulou (Part 2 of 2) Imperial College London 20:02 1 day ago 131 Далее Скачать
ASCO 2023 Expert Report on novelties in oncogene driven NSCLC by A. Curioni-Fontecedro European Society for Medical Oncology (ESMO) 4:47 1 year ago 969 Далее Скачать
INTERLACE: induction chemotherapy + CRT as new SOC in locally advanced cervical cancer VJOncology 1:18 1 year ago 503 Далее Скачать
Breakthroughs in urothelial cancer treatment at ESMO 2023 VJOncology 3:38 1 year ago 421 Далее Скачать
Tisotumab Vedotin for Metastatic Cervical Cancer: Results From ESMO 2023 With Brian Slomovitz, MD Oncology Data Advisor 4:58 1 year ago 266 Далее Скачать
Future directions of the RCT assessing follow-up management of gynecological cancer VJOncology 1:43 11 months ago 47 Далее Скачать
Highlights on amivantamab after progression on osimertinib in EGFR-mutated NSCLC: MARIPOSA-2 European Society for Medical Oncology (ESMO) 4:17 1 year ago 1 618 Далее Скачать
Gynecologic Cancer Immunotherapy: New potential in gynecologic cancers Cancer Research Institute 36:20 2 years ago 2 424 Далее Скачать
#ESMO21 Highlights on pembro + chemo in 1st-line metastatic cervical cancer: The KEYNOTE-826 study European Society for Medical Oncology (ESMO) 2:26 3 years ago 2 388 Далее Скачать
Highlights on Lu-PSMA-617 in taxane-naive patients with mCRPC: The PSMAfore study European Society for Medical Oncology (ESMO) 3:25 1 year ago 1 706 Далее Скачать